Subscribe
Sign In
|
Subscribe
Hims & Hers Launches Peptides Despite Efficacy Risks
Constantino & Gomez
CNBC November 19, 2026
Google DeepMind
The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.
Continue Reading⟶
Comment
Show comments
Hide Comments
Log In with your RCMG Account
Register
Related Articles